Advisor Group Holdings, Inc. Bellus Health Inc. Transaction History

Advisor Group Holdings, Inc.

8 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 14, 2022	SELL	$8.95 - $12.0 $8 - $12	-1 Reduced 0.04%	2,400 $25,000
Q2 2022 Aug 10, 2022	BUY	$6.46 - $10.02 $6 - $10	1 Added 0.04%	2,401 $22,000
Q1 2022 May 04, 2022	SELL	$5.56 - $7.99 $1,667 - $2,397	-300 Reduced 11.11%	2,400 $17,000
Q3 2021 Nov 05, 2021	BUY	$2.7 - $6.64 $6,480 - $15,936	2,400 Added 800.0%	2,700 $17,000
Q2 2021 Aug 02, 2021	BUY	$3.11 - $4.61 $933 - $1,383	300 New	300 $1,000
Q1 2021 May 13, 2021	SELL	$3.03 - $4.58 $2,121 - $3,206	-700 Closed	0 $0
Q4 2020 Feb 10, 2021	BUY	$2.27 - $3.3 $454 - $660	200 Added 40.0%	700 $3,000
Q2 2020 Aug 14, 2020	BUY	$8.88 - $11.15 $4,440 - $5,575	500 New	500 $5,000

128K

Ticker BLU
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 125,793,000
Description
BELLUS Health Inc., a clinical stage biopharmaceutical company, develops therapeutics for the treatment of refractory chronic cough (RCC) and other cough hypersensitivity indications. Its lead product candidate includes BLU-5937, an antagonist of the P2X3 receptor, which is in Phase II clinical trial for treatment of RCC and chronic pruritus. Th...

Get notified when there are updates to the investment portfolio of Advisor Group Holdings, Inc., based on Form 13F filings with the SEC.

Stay updated on Advisor Group Holdings, Inc. with notifications on news.